Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea · Delayed Price · Currency is KRW 2,365.00
+5.00 (0.21%)
At close: Aug 24, 2026
Korea Arlico Pharm Market Cap
Korea Arlico Pharm has a market cap or net worth of 36.17 billion as of August 21, 2026. Its market cap has decreased by -48.30% in one year.
Market Cap
36.17B
Enterprise Value
59.93B
Revenue
199.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,365.00
ChartMarket Cap Chart
Since February 12, 2018, Korea Arlico Pharm's market cap has decreased from 207.83B to 36.17B, a decrease of -82.60%. That is a compound annual growth rate of -18.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 36.17B | -44.80% |
| Dec 30, 2025 | 65.52B | 23.73% |
| Dec 30, 2024 | 52.95B | -39.39% |
| Dec 28, 2023 | 87.36B | -12.98% |
| Dec 29, 2022 | 100.39B | -14.71% |
| Dec 30, 2021 | 117.71B | -17.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jin Yang Pharmaceutical | 50.93B |
| Samik Pharmaceutical Company LTD. | 49.58B |
| RP Bio | 48.44B |
| Organoidsciences | 45.44B |
| GeneBioTech Co. ,Ltd | 40.17B |
| Eagle Veterinary Technology Co.,Ltd | 38.68B |
| Korean Drug | 37.16B |
| Kyung Nam Pharm | 30.12B |